Skip to main content
Have a personal or library account? Click to login
CAD at the Intersection of Cardiology and Rheumatology: Focus on Cardiovascular Imaging Cover

CAD at the Intersection of Cardiology and Rheumatology: Focus on Cardiovascular Imaging

Open Access
|Oct 2025

References

  1. Mortensen MB, Jensen JM, Rønnow Sand NP, et al. Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events. J Am Coll Cardiol. 2024 Jun 25;83(25):2643-2654. doi: 10.1016/j.jacc.2024.04.030
  2. DiGregorio H, Avenatti E, Gullapelli R, et al. Burden of Atherosclerotic Disease Risk Factors in Patients With and Without Rheumatologic Disease: A Retrospective Cohort Study. Am J Cardiol. 2024 Nov 1:230:37-40. doi: 10.1016/j.amjcard.2024.08.017
  3. Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022 Mar 20;23(6):3346. doi: 10.3390/ijms23063346
  4. Bottardi A, Prado GFA, Lunardi M, et al. Clinical updates in coronary artery disease: A comprehensive review. J Clin Med. 2024 Aug 6;13(16):4600. doi: 10.3390/jcm13164600
  5. Abohelwa M, Kopel J, Shurmur S, Ansari MM, Awasthi Y, Awasthi S. The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review. J Vasc Dis. 2023 Feb 13;2(1):164. doi: 10.3390/jvd2010010
  6. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: A meta-analysis of observational studies. Ann Rheum Dis. 2012 Sep;71(9):1524-9
  7. Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022 Sep 3;400(10354):733-743. doi: 10.1016/S0140-6736(22)01349-6
  8. Steyers CM 3rd, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014 Jun 25;15(7):11324-49. doi: 10.3390/ijms150711324
  9. Ridker PM, Everett BM, Thuren T, et al; CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914
  10. Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013 Jan 29;61(4):404-410. doi: 10.1016/j.jacc.2012.10.027
  11. Nidorf SM, Fiolet ATL, Mosterd A, et al. LoDoCo2 Trial Investigators. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372
  12. Tardif J, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388
  13. Taqueti VR, Everett BM, Murthy VL, et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10;131(6):528-35. doi: 10.1161/CIRCULATIONAHA.114.009716
  14. Cecere A, Perazzolo Marra M, et al. Coronary microvascular dysfunction in autoimmune rheumatic diseases: Beyond coronary flow velocity reserve. Front Cardiovasc Med. 2024 Aug 21:11:1372703. doi: 10.3389/fcvm.2024.1372703
  15. Turiel M, Atzeni F, Tomasoni L, et al. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford). 2009 Jul;48(7):834-9. doi: 10.1093/rheumatology/kep082
  16. Hirata K, Kadirvelu A, Kinjo M, et al. Altered coronary vasomotor function in young patients with systemic lupus erythematosus. Arthritis Rheum. 2007 Jun;56(6):1904-9. doi: 10.1002/art.22702
  17. Mavrogeni SI, Markousis-Mavrogenis G, Karapanagiotou O, et al. Silent myocardial perfusion abnormalities detected by stress cardiovascular magnetic resonance in antiphospholipid syndrome: A case-control study. J Clin Med. 2019 Jul 23;8(7):1084. doi: 10.3390/jcm8071084
  18. Wilkinson MJ, Shapiro MD. Immune-mediated inflammatory diseases, dyslipidemia, and cardiovascular risk: A complex interplay. Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2396-2406. doi: 10.1161/ATVBAHA.124.319983
  19. Lu Y, Cui X, Zhang L, et al. The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy. Aging Dis. 2022 Apr 1;13(2):491-520. doi: 10.14336/AD.2021.0929
  20. Venetsanopoulou AI, Pelechas E, Voulgari PV, Drosos AA. The lipid paradox in rheumatoid arthritis: The dark horse of the augmented cardiovascular risk. Rheumatol Int. 2020 Aug;40(8):1181-1191. doi: 10.1007/s00296-020-04616-2
  21. Avenatti E, DiGregorio H, Hajj EE, et al. Disparities in statin use in patients with ASCVD with vs without rheumatologic diseases in a large integrated healthcare system: Houston methodist CVD learning health system registry. Am J Prev Cardiol. 2025 Mar 28:22:100959. doi: 10.1016/j.ajpc.2025.100959
  22. Weber BN, Paik JJ, Aghayev A, et al. Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement. J Am Coll Cardiol. 2023 Nov 28;82(22):2128-2151. doi: 10.1016/j.jacc.2023.09.819
  23. Mavrogeni S, Pepe A, Nijveldt R, et al. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022 Aug 22;23(9):e308-e322. doi: 10.1093/ehjci/jeac134
  24. Saghir MK, Attenhofer Jost C, Warrington KJ, Cha SS, Pellikka PA. Exercise echocardiography in rheumatoid arthritis: A case-control study. J Am Soc Echocardiogr. 2009 Nov;22(11):1228-31. doi: 10.1016/j.echo.2009.07.018
  25. Toutouzas K, Sfikakis PP, Karanasos A, et al. Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis: hypothesis-generating insights from a cross-sectional study. Rheumatology (Oxford). 2013 Jan;52(1):76-80. doi: 10.1093/rheumatology/kes349
  26. Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by doppler echocardiography: Comparison with invasive technique. J Am Coll Cardiol. 1998 Nov;32(5):1251-9. doi: 10.1016/s0735-1097(98)00389-1
  27. Jukema RA, Dahdal J, Kooijman EM, et al. Diagnostic accuracy of non-invasive cardiac imaging modalities in patients with a history of coronary artery disease: a meta-analysis. Heart. 2024 Dec 13;111(1):4-10. doi: 10.1136/heartjnl-2024-324248
  28. Erre GL, Buscetta G, Paliogiannis P, et al. Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis. Rheumatol Int. 2018 Jul;38(7):1179-1190. doi: 10.1007/s00296-018-4039-8
  29. Yılmaz S, Caliskan M, Kulaksızoglu S, et al. Association between serum total antioxidant status and coronary microvascular functions in patients with SLE. Echocardiography. 2012 Nov;29(10):1218-23. doi: 10.1111/j.1540-8175.2012.01797.x
  30. Caliskan M, Erdogan D, Gullu H, et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis. 2008 Jan;196(1):306-312. doi: 10.1016/j.atherosclerosis.2006.11.003
  31. Ikonomidis I, Makavos G, Papadavid E, et al. Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: The role of oxidative stress and inflammation. Can J Cardiol. 2015 Mar;31(3):287-95. doi: 10.1016/j.cjca.2014.11.002
  32. Piaserico S, Papadavid E, Cecere A, et al. Coronary microvascular dysfunction in asymptomatic patients with severe psoriasis. J Invest Dermatol. 2023 Oct;143(10):1929-1936.e2. doi: 10.1016/j.jid.2023.02.037
  33. Sincer İ, Kurtoğlu E, Yılmaz Çoşkun F, et al. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study. Anatol J Cardiol. 2015 Nov;15(11):913-8. doi: 10.5152/akd.2015.5764
  34. Ikonomidis I, Papadavid E, Makavos G, et al. Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis. Circ Cardiovasc Imaging. 2017 Sep;10(9):e006283. doi: 10.1161/CIRCIMAGING.117.006283
  35. Ikonomidis I, Tzortzis S, Andreadou I, et al. Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circ Cardiovasc Imaging. 2014 Jul;7(4):619-28. doi: 10.1161/CIRCIMAGING.113.001193
  36. Mitchell JD, Paisley R, Moon P, Novak E, Villines TC. Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke: The walter reed cohort study. JACC Cardiovasc Imaging. 2018 Dec;11(12):1799-1806. doi: 10.1016/j.jcmg.2017.09.003
  37. Martínez-Ceballos MA, Sinning Rey JC, Alzate-Granados JP, et al. Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis. Atherosclerosis. 2021 Oct:335:68-76. doi: 10.1016/j.atherosclerosis.2021.09.017
  38. Romero-Díaz J, Vargas-Vóracková F, Kimura-Hayama E, et al. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford). 2012 Jan;51(1):110-9. doi: 10.1093/rheumatology/ker307
  39. Rho YH, Chung CP, Oeser A, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009 Nov 15;61(11):1580-5. doi: 10.1002/art.25009
  40. Feher A, Pieszko K, Miller R, et al. Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imaging. J Nucl Cardiol. 2023 Apr;30(2):590-603. doi: 10.1007/s12350-022-03099-x
  41. Feher A, Pieszko K, Shanbhag A, et al. Comparison of the prognostic value between quantification and visual estimation of coronary calcification from attenuation CT in patients undergoing SPECT myocardial perfusion imaging. Int J Cardiovasc Imaging. 2024 Jan;40(1):185-193. doi: 10.1007/s10554-023-02980-1
  42. Luo Y, Hanuska D, Xu J, Salvatore MM, Bernstein EJ. Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features. Semin Arthritis Rheum. 2025 Feb:70:152598. doi: 10.1016/j.semarthrit.2024.152598
  43. Hamon M, Biondi-Zoccai GGL, Malagutti P, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol. 2006 Nov 7;48(9):1896-910. doi: 10.1016/j.jacc.2006.08.028
  44. Priester TC, Litwin SE. Measuring progression of coronary atherosclerosis with Computed tomography: Searching for clarity Among Shades of gray. J Cardiovasc Comput Tomogr. 2009 Nov-Dec:3 Suppl 2:S81-90. doi: 10.1016/j.jcct.2009.10.011
  45. Thomsen C, Abdulla J. Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):120-9. doi: 10.1093/ehjci/jev325
  46. Karpouzas GA, Malpeso J, Choi T, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014 Oct;73(10):1797-804. doi: 10.1136/annrheumdis-2013-203617
  47. Stojan G, Li J, Budoff M, Arbab-Zadeh A, Petri MA. High-risk coronary plaque in SLE: Low-attenuation non-calcified coronary plaque and positive remodelling index. Lupus Sci Med. 2020 Jul;7(1):e000409. doi: 10.1136/lupus–;000409
  48. Rajiah P, Cummings KW, Williamson E, Young PM. CT Fractional Flow Reserve: A Practical Guide to Application, Interpretation, and Problem Solving. Radiographics. 2022 Mar-Apr;42(2):340-358. doi: 10.1148/rg.210097
  49. Shields KJ, Barinas-Mitchell E, Gingo MR, et al. Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women. Atherosclerosis. 2013 Nov;231(1):129-35. doi: 10.1016/j.atherosclerosis.2013.09.004
  50. Shields KJ, El Khoudary SR, Ahearn JM, Manzi S. Association of aortic perivascular adipose tissue density with aortic calcification in women with systemic lupus erythematosus. Atherosclerosis. 2017 Jul:262:55-61. doi: 10.1016/j.atherosclerosis.2017.04.021
  51. Antonopoulos AS, Sanna F, Sabharwal N, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017 Jul 12;9(398):eaal2658. doi: 10.1126/scitranslmed.aal2658
  52. Thornton E, Mendiratta-Lala M, Siewert B, Eisenberg RL. Patterns of fat stranding. AJR Am J Roentgenol. 2011 Jul;197(1):W1-14. doi: 10.2214/AJR.10.4375
  53. Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): A post-hoc analysis of prospective outcome data. Lancet. 2018 Sep 15;392(10151):929-939. doi: 10.1016/S0140-6736(18)31114-0
  54. Elnabawi YA, Oikonomou EK, Dey AK, et al. Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index. JAMA Cardiol. 2019 Sep 1;4(9):885-891. doi: 10.1001/jamacardio.2019.2589
  55. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000 Nov 16;343(20):1445-53. doi: 10.1056/NEJM200011163432003
  56. Mavrogeni SI, Sfikakis PP, Koutsogeorgopoulou L, et al. Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases. JACC Cardiovasc Imaging. 2017 Nov;10(11):1387-1396. doi: 10.1016/j.jcmg.2017.08.017
  57. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003 Jul 29;108(4):432-7. doi: 10.1161/01.CIR.0000080915.35024.A9
  58. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012 Feb 4;379(9814):453-60. doi: 10.1016/S0140-6736(11)61335-4
  59. Kotecha T, Martinez-Naharro A, Boldrini M, et al. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology. JACC Cardiovasc Imaging. 2019 Oct;12(10):1958-1969. doi: 10.1016/j.jcmg.2018.12.022
  60. Kobayashi Y, Giles JT, Hirano M, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther. 2010 Sep;12(5):R171. doi: 10.1186/ar3131
  61. Sacré K, Brihaye B, Hyafil F, et al. Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study. Arthritis Rheum. 2010 Jul;62(7):2093-100. doi: 10.1002/art.27488
  62. Ishimori ML, Martin R, Berman DS, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging. 2011 Jan;4(1):27-33. doi: 10.1016/j.jcmg.2010.09.019
  63. Sandhu VK, Wei J, Thomson LEJ, et al. Five-Year Follow-Up of Coronary Microvascular Dysfunction and Coronary Artery Disease in Systemic Lupus Erythematosus: Results From a Community-Based Lupus Cohort. Arthritis Care Res (Hoboken). 2020 Jul;72(7):882-887. doi: 10.1002/acr.23920
  64. Dumitru RB, Bissell L, Erhayiem B, et al. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis. Rheumatology (Oxford). 2021 Jun 18;60(6):2934-2945. doi: 10.1093/rheumatology/keaa742
  65. Feher A, Sinusas AJ. Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2017 Aug;10(8):e006427. doi: 10.1161/CIRCIMAGING.117.006427
  66. Weber, B, Weisenfeld, D, Massarotti, E, et al.Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results From the LiiRA Study. J Am Heart Assoc. 2024 May 7;13(9):e030387. doi: 10.1161/JAHA.123.030387
  67. Weber B, Weisenfeld D, Seyok T, et al. Relationship between risk of atherosclerotic cardiovascular disease, inflammation, and coronary microvascular dysfunction in rheumatoid arthritis. J Am Heart Assoc. 2022 Jun 7;11(11):e025467. doi: 10.1161/JAHA.121.025467
  68. Amigues I, Russo C, Giles JT, et al. Myocardial microvascular dysfunction in rheumatoid arthritis; Quantitation by 13N-ammonia positron emission tomography/computed tomography. Circ Cardiovasc Imaging. 2019 Dec;12(1):e007495. doi: 10.1161/CIRCIMAGING.117.007495
  69. Feher A, Boutagy NE, Oikonomou EK, et al. Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography/Computed Tomography in Patients With Systemic Sclerosis. J Rheumatol. 2021 Oct;48(10):1574-1582. doi: 10.3899/jrheum.210040
  70. Feher A, Boutagy NE, Oikonomou EK, et al. Association Between Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography Imaging and Adverse Events in Patients With Autoimmune Rheumatic Disease. Circ Cardiovasc Imaging. 2021 Sep;14(9):e012208. doi: 10.1161/CIRCIMAGING.120.012208
  71. Weber BN, Stevens E, Perez-Chada LM, et al. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 Nov;14(11):2212-2220. doi: 10.1016/j.jcmg.2020.12.031
  72. Weber BN, Stevens E, Barrett L, et al. Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. J Am Heart Assoc. 2021 Jul 6;10(13):e018555. doi: 10.1161/JAHA.120.018555
  73. Weber B, Perez-Chada LM, Divakaran S, et al. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022 Feb;29(1):37-42. doi: 10.1007/s12350-020-02166-5
  74. Ogawa M, Nakamura S, Saito Y, Kosugi M, Magata Y. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro. J Nucl Med. 2012 Jan;53(1):55-8. doi: 10.2967/jnumed.111.092866
  75. Figueroa AL, Abdelbaky A, Truong QA, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging. 2013 Dec;6(12):1250-9. doi: 10.1016/j.jcmg.2013.08.006
  76. Kubota K, Yamashita H, Mimori A. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis. Semin Nucl Med. 2017 Jul;47(4):408-424. doi: 10.1053/j.semnuclmed.2017.02.005
  77. Boczar KE, Beanlands RS, Glassman SJ, et al. Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study. J Nucl Cardiol. 2023 Aug;30(4):1642-1652. doi: 10.1007/s12350-023-03204-8
  78. Mäki-Petäjä KM, Elkhawad M, Cheriyan J, et al. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation. 2012 Nov 20;126(21):2473-80. doi: 10.1161/CIRCULATIONAHA.112.120410
  79. Zureigat H, Civieri G, Abohashem S, et al. Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis. J Nucl Cardiol. 2024 Mar:33:101813. doi: 10.1016/j.nuclcard.2024.101813
  80. Maier A, Teunissen AJP, Nauta SA, Lutgens E, Fayad ZA, van Leent MMT. Uncovering atherosclerotic cardiovascular disease by PET imaging. Nat Rev Cardiol. 2024 Sep;21(9):632-651. doi: 10.1038/s41569-024-01009-x
DOI: https://doi.org/10.14797/mdcvj.1646 | Journal eISSN: 1947-6108
Language: English
Page range: 65 - 75
Submitted on: May 26, 2025
Accepted on: Jun 19, 2025
Published on: Oct 1, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2025 Kenneth Wade Williams, Helene DiGregorio, Deepak Jagannath, Attila Feher, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.